Compugen (CGEN) Cash from Investing Activities (2009 - 2010)

Compugen (CGEN) posted quarterly Cash from Investing Activities of $3.0 million for Q4 2010, up 651.12% year-over-year from $394746.3 in Q4 2009, and up 140.55% on a QoQ basis from -$7.3 million in Q3 2010.

Compugen (CGEN) Cash from Investing Activities (2009 - 2010) Analysis & Trends

Compugen has reported Cash from Investing Activities for 2 years, with the latest figure at $3.0 million in Q4 2010.

  • Cash from Investing Activities for Q4 2010 came in at $3.0 million, up 651.12% year-over-year; the trailing twelve-month figure through Dec 2010 was -$4.9 million (changed N/A YoY), and the FY2025 annual result was $30.0 million, up 164.85% from the prior year.
  • Cash from Investing Activities climbed to $3.0 million in Q4 2010, from -$7.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $3.0 million in Q4 2010 and troughed at -$7.3 million in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -1.66 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -49.35 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 19.77 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -229.72 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -363.46 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 24.51 Mn
10 Compugen 227.88 Mn 136.13 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 2.97 Mn
Dec 31, 2010 2.97 Mn
Sep 30, 2010 -7.31 Mn
Sep 30, 2010 -7.31 Mn
Dec 31, 2009 -538,000.00
Dec 31, 2009 -538,000.00
Sep 30, 2009 18,000.00
Sep 30, 2009 18,000.00